The QualityStocks Daily Friday, June 5th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (SQZZF) +78.45%

StockMarketWatch (CHK) +76.51%

Schaeffer's (HTZ) +71.33%

The QualityStocks Daily Stock List

Jushi Holdings, Inc. (JUSHF)

NetworkNewsWire, PR Newswire, Market Wire News, InvestorX, OTC Markets, MG Retailer, New Cannabis Ventures, Stock Digest, Cannabis Daily, Barchart, Street Insider, Wallmine, OTC.Watch, Stockhouse, Penny Stock Hub, CannabisFN.com, Corporate Knights, Highwater Financial, Talkmarkets, BioSpace, Green Market Report, NIC Investors, Cannabis News Wire, Stockwatch, Energy and Capital, and Investing News reported earlier on Jushi Holdings, Inc. (JUSHF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Jushi Holdings, Inc. is a globally-focused, multi-state cannabis and hemp operator. It is focused in the United States on building a multi-state portfolio of branded cannabis and hemp-derived assets through opportunistic acquisitions, distressed workouts, and competitive applications. Founded in 2018, Jushi Holdings is headquartered in Boca Raton, Florida. The Company lists on the OTC Markets’ OTCQX.

Jushi’s mission is to create an integrated worldwide community of wellness, mindfulness, and connections through superior quality cannabis and hemp-derived products. The Company’s brands include Beyond/Hello, Nira, The Lab, and The Bank.

Beyond/Hello is a brand of cannabis dispensaries. Nira is a new line of hemp-based CBD (cannabidiol) products, which are physician-formulated and produced with full-spectrum hemp. Nira products are developed under the guidance of Dr. Laszlo Mechtler, MD, FAAN, FASN, FEAN, Professor of Neurology Oncology.

The Lab infused production facility has been in operation since 2010. At present, this Lab is producing more than one million grams of concentrate across 70-plus product formulations in a calendar year. The Bank genetics has been producing premier cannabis seeds and flower for the past 10 years.

In May, Jushi Holdings announced the start of adult-use sales at its dispensary in Normal, Illinois (Bloomington-Normal metropolitan area). The Company’s Illinois dispensaries now operate under the Company's BEYOND/HELLO™ brand.

This week, Jushi Holdings announced the voting results of the annual and special meeting of shareholders of the Corporation that was held on June 3, 2020. Regarding the election of the six nominated Directors, the number of Directors of the Corporation was fixed at six and all six nominees set forth in the Management Information Circular of the Corporation, dated May 4, 2020, were elected as Directors of the Corporation. MNP LLP was reappointed as the auditor of the Corporation.

Jushi Holdings expects to report its financial results for Q1 ended March 31, 2020, and its accompanying management discussion and analysis on or before July 14, 2020.

Jushi Holdings, Inc. (JUSHF), closed Friday's trading session at $1.08, up 4.9068%, on 17,241 volume with 24 trades. The average volume for the last 3 months is 31,690 and the stock's 52-week low/high is $0.25999999/$2.51810002.

Kona Gold Solutions, Inc. (KGKG)

Discovery Stocks, NIC Investors, Micro Cap Daily, Talkmarkets, Stockwatch, Business Wire, Stockhouse, Wallmine, Trading View, Market Screener, Accesswire, 4-Traders, Dividend.com, InvestorNews.ca, Dividend Investor, InvestorsHub, Wallet Investor, PotStocks.online, and Insider Financial reported beforehand on Kona Gold Solutions, Inc. (KGKG), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Kona Gold Solutions, Inc. is a hemp and CBD (cannabidiol) lifestyle brand centered on product development in the functional beverage sector. It has created wholly-owned subsidiaries, Kona Gold LLC, HighDrate, LLC, and Gold Leaf Distribution, LLC. The Companies are located on the east coast of Florida in Melbourne and Greer, South Carolina. Kona Gold Solutions’ shares trade on the OTC Markets Group’s OTCQB.

Subsidiary Kona Gold, LLC has developed a premium Hemp Infused Energy Drink line. The HighDrate, LLC subsidiary has developed the beverage industry’s first CBD Energy Water, available in six flavors. The Gold Leaf Distribution, LLC subsidiary was created to fill Kona Gold Solutions’ distribution needs in markets it wants to quickly enter.

Kona Gold Solutions’ Kona Gold Hemp Energy Drink line extension includes Bubble Gum and Candy Apple flavors. The line extension for its HighDrate CBD Energy Waters includes Blue Island Punch and Sour Apple. Kona Gold Solutions also has its Pink Grapefruit Hemp Energy Drink, Kona Pink.

In May, Kona Gold Solutions announced an increase in sales during Q2 of 2020. The Company reported an increase of sales in its wholly-owned subsidiaries, Kona Gold LLC, and Gold Leaf Distribution LLC. Kona Gold's Statewide distributor in Alabama, Alabev, hit their Quarter 1 target numbers in sales of Kona Gold's hemp energy drinks. The Company's Statewide distributor in Michigan, which presently distributes Kona Gold's hemp energy drinks, will be bringing the Company's HighDrate CBD Energy Waters and Storm CBD Waters into their markets this month.

Gold Leaf Distribution, who distributes Kona Gold products and other beverage products in Florida and South Carolina, continues to experience month-over-month growth. Gold Leaf was having a record month in May. Gold Leaf delivers product to close to 700 retail locations. This includes more than 200 Circle K's, BI-LO's, Piggly Wiggly's, 7-Eleven's, BP's, and many various independent retail locations.

Kona Gold Solutions, Inc. (KGKG), closed Friday's trading session at $0.0275, up 6.5891%, on 3,697,773 volume with 187 trades. The average volume for the last 3 months is 3,512,969 and the stock's 52-week low/high is $0.020999999/$0.129899993.

n

Lixte Biotechnology Holdings, Inc. (LIXT)

OTC Markets, Research and Markets, BioPortfolio, P&T Community, Dividend Investor, Spotlight Growth, Wallet Investor, PR Newswire, Dividata, Stockopedia, PipelineReview.com, Stockhouse, GuruFocus, Emerging Growth, Simply Wall St, last10k, Small Cap Network, Morningstar, Specialty Pharma Journal, Street Insider, hot Stocked, 4-Traders, and InvestorsHub reported earlier on Lixte Biotechnology Holdings, Inc. (LIXT), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. It uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. Its product pipeline is primarily centered on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or X-ray and immune checkpoint blockers. A clinical-stage pharmaceutical company, Lixte Biotechnology Holdings is headquartered in East Setauket, New York. The Company’s shares trade on the OTCQB.

Lixte has identified molecular signaling pathways altered in disease states. The Company has also designed compounds that can safely target them in animal models. Lixte’s present drug portfolio includes inhibitors of serine/threonine protein phosphatases critical to cell division and DNA damage repair and inhibitors of protein deacetylases, which regulate pathways of gene expression and protein degradation.

The phosphatase inhibitors enhance the effectiveness of cytotoxic anti-cancer drugs in general and radiation therapy. This makes them potentially useful for the treatment of numerous cancers in combination with existing standard chemotherapy regimens and with the developing targeted cytotoxic therapies of personalized cancer medicine.

Additionally, in a pre-clinical study done with scientists under collaborative research and development (R&D) agreements at the National Institutes of Health, Lixte Biotechnology’s lead compound, LB-100, enhanced the antitumor activity of a major immune checkpoint inhibitor. Therefore, this raises the possibility that in addition to improving the efficacy of standard cytotoxic anti-cancer drugs, Lixte’s phosphatase inhibitors may potentiate immunotherapy regimens (Ho 2017).

At the end of April, Lixte Biotechnology Holdings noted that investigators at the National Cancer Institute (NCI) and National Institute of Neurological Disorders and Stroke (NINDS) reported that the Company’s lead clinical compound, LB-100, enhanced pharmacological immunotherapy of intracranial brain tumors in immune-competent mice. This includes 25 percent complete regression and immunity to tumor rechallenge (Journal of Neuro-oncology, on-line April 27, 2020).

Dr. John S. Kovach, Chief Executive Officer of Lixte Biotechnology and one of the authors of the article, said, “The new article reports that the combination of LB-100 plus a PD1 blocker shrank the GBM cancers implanted in the brain, including elimination of tumor and development of immunity to re-challenge with the same tumor in 25% of the animals. These investigators had previously shown that LB-100 enhances the anti-tumor activity of a PD1 blocker in a mouse model of colon cancer but this is the first report that inhibition of PP2A activity improves the efficacy of PD1 blockade in a model of GBM.”

Lixte Biotechnology Holdings, Inc. (LIXT), closed Friday's trading session at $0.90, even for the day, on 5,000 volume with 1 trade. The average volume for the last 3 months is 2,221 and the stock's 52-week low/high is $0.564999997/$1.39999997.

Plymouth Rock Technologies, Inc. (PLRTF)

Mining Stock Education, The Deep Dive, Market Tactic, Simply Wall St, OTC Markets, Seeking Alpha, Wallet Investor, Stockhouse, Investor Ideas, Nasdaq, Investing News, P&T Community, last10k, Dividend.com, PR Newswire, Stockwatch, Dividend Investor, Investing News, Ask Finny, MarketWatch, Barchart, Canadian Insider, GuruFocus, and Newsfilecorp reported earlier on Plymouth Rock Technologies, Inc. (PLRTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Plymouth Rock Technologies, Inc. is a leader in the development of pioneering threat detection technologies. The Company’s mission is to bring engineering-driven answers to the most critical problems that threaten safety. Its products, both airborne and land-based, will scan for threat items at greater "stand-off" distances than present existing technologies. Fundamentally, the Company’s solutions leverage Artificial Intelligence (AI), to create new capabilities for the early detection of threats, to protect those who serve and the general public. OTCQB-listed, Plymouth Rock Technologies has its head office in Plymouth, Massachusetts.

The Company’s team combines practical expertise in radio technologies, mechatronics, design, software, and AI. Plymouth Rock works with government, law enforcement, and military to innovate solutions for national security, defense, as well as space systems.

Plymouth Rock Technologies is developing the next generation of threat detection solutions. The PRT X1 is a purpose built multirotor Unmanned Aircraft System (UAS). The unit contains an integrated sensor package, which combines Thermal detection with 4K HD real-time air-to-ground streaming. The Company’s advanced threat detection methods fuse AI with augmented reality interfaces to eliminate human operating error.

Plymouth Rock's other core technologies include a Millimeter Remote Imaging from Airborne Drone (MIRIAD); and a compact microwave radar system for scanning shoe's (Shoe-Scanner). The Company’s innovative radar imaging and signal processing technology creates new opportunities for remotely operated, nonintrusive screening of crowds in real time.

Between 1983-1985, Plymouth Rock Technologies developed the first millimeter-wave silicon monolithic high-power PIN Diode arrays for W-Band Radar for the US Army. Between 1991 – 1993, the Company commercially sold the first Automotive radars for cruise control and blind spot detection for use in buses and large trucks. Moreover, from 2005-2009, it developed and produced W-Band transceivers for landing aircraft in Degraded Visual Environments (DVE).

This week, Plymouth Rock Technologies announced that Mr. Marshall Sterman was appointed to the Company's Board of Advisors. Mr. Sterman brings decades of wide-ranging financial experience to Plymouth Rock Technologies. This includes positions at Burbank & Co.; Sterman & Gowell (private placements, underwriting, venture finance); Croesus Capital (reorganization/work-outs for institutional clients); Managing Director at The Bank House (Merchant Bank); and The Mayflower Group (private equity, restructuring).

Plymouth Rock Technologies, Inc. (PLRTF), closed Friday's trading session at $0.3945, up 5.20%, on 371,880 volume with 196 trades. The average volume for the last 3 months is 109,533 and the stock's 52-week low/high is $0.061/$0.600000023.

RocketFuel Blockchain, Inc. (RKFL)

OTC Dynamics, Coin Spectator, Global Banking and Finance, Zacks, Insider Tracking, Barchart, Central Charts, Accesswire, EIN Presswire, Corporate Information, TipRanks, Market Screener, Seeking Alpha, InvestorsHub, TradingView, Dividend Investor, YCharts, Street Insider, Nasdaq, OTC Markets, Simply Wall St, last10k, Stockopedia, GuruFocus, Stockwatch, MarketWatch, GlobeNewswire, Morningstar, Macrotrends, Business Wire, and Investors Hangout reported earlier on RocketFuel Blockchain, Inc. (RKFL), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

RocketFuel Blockchain, Inc. is a developer of blockchain-based privacy protection technologies. It is developing blockchain-based technologies to bring highly efficient check-out and privacy protection solutions to eCommerce and brick and mortar merchants and their customers. The Company’s mission is to provide Blockchain based check-out solutions that securely automate and simplify the way online payment and shipping information are received from customers. RocketFuel Blockchain has its corporate headquarters in Las Vegas, Nevada.

The design of the blockchain technologies developed by the Company are to focus on enhanced customer privacy protection eliminating the risk of data breach. This is while increasing the speed, the security, as well as the ease of use. The RocketFuel Blockchain management team consists of experienced professionals with significant domain experience in Internet based payment and banking companies.

Recently, RocketFuel Blockchain and Sila (the built-in ACH and digital wallet API provider) announced a partnership to transform and disrupt the monopolized and rigid payment regimes. This partnership will see RocketFuel’s ultra high efficiency ecommerce blockchain based check-out technology platform, join Sila build-in digital wallet with linked bank-account to reach millions of new customers and sales channels.

Sila provides Banking and Payments Infrastructure-as-a-Service for teams building the next generation of financial products and services. Sila’s banking APIs replace the need for integrating with legacy financial institutions saving months of development time, and thousands in legal and regulatory expenses. This partnership between RocketFuel Blockchain and Sila enables the companies to expand the frictionless and simple payment and check-out solutions to eCommerce and brick-and-mortar merchants and simultaneously broaden the sales channels considerably.

In May, RocketFuel Blockchain announced the completion of a $500,000 private placement with a private group of strategic investors. This financing also provided for the grant of a one-year common stock purchase warrant exercisable into 1,500,000 shares of RocketFuel’s’s common stock.

Gert Funk, RocketFuel Blockchain’s Chief Executive Officer, stated, “This financing arrangement is pivotal in continuing the execution of both our short- and long-term strategic plans. The initial tranche of $500,000 provides us the working capital to continue the development of our core blockchain-based technologies and to support our recently announced strategic partnership which should generate near-term revenues.”

RocketFuel Blockchain, Inc. (RKFL), closed Friday's trading session at $2.25, even for the day, on 100 volume with 1 trade. The average volume for the last 3 months is 368 and the stock's 52-week low/high is $0.500100016/$7.00.

Searchlight Resources, Inc. (CNYCF)

Zacks, Invezz.com, Junior Mining Network, Market Screener, Central Charts, Macrotrends, GuruFocus, TradingView, Investing News, Seeking Alpha, Barchart, Trade Ideas, All Stocks Today, Stockwatch, Stockhouse, TMXmoney, InvestorsHub, Dividend Investor, Investment Pitch, MarketWatch, Morningstar, and Interactive Brokers reported previously on Searchlight Resources, Inc. (CNYCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Searchlight Resources, Inc. is a mineral exploration and development company headquartered in Vancouver, British Columbia. It acquires, explores for, and develops mineral properties in Canada and the United States. The Company concentrates on developing and maintaining a high-quality exploration team, which permits Searchlight to evaluate, explore, and steadily advance projects while being continuously active seeking new ventures. Established in 2000, the Company formerly went by the name Canyon Copper Corp. It changed its name to Searchlight Resources, Inc. in July of 2018.

Searchlight Resources focuses on finding mines through targeting well defined projects in low risk and well-regulated jurisdictions - Saskatchewan, Nevada, and Ontario; known mining belts – Flin Flon & Kidd Munro Assemblage of the Abitibi Greenstone Belt; and close to access, infrastructure, and experienced staff – Flin Flon, Timmins.

The Company has a major emphasis on high grade gold in known Saskatchewan gold camps - geology similar to the Red Lake gold camp in Ontario, but underexplored. Searchlight’s skilled exploration team continually evaluates low acquisition cost opportunities in Saskatchewan. This includes gold, copper, zinc, cobalt, vanadium, rare earths, and technology elements targets.

Company highlights include the English Bay high grade gold, with open pit and underground potential on a highway less than 10 kilometers from La Ronge. English Bay has numerous high grade drill gold intersections including 2.10 oz/t Au over 4 ft (72.0 g/t Au over 1.2 m), and 1.85 oz/t Au over 4.5 ft (63.43 Au g/t over 1.4m).

In addition, Bootleg Lake targets an extensive gold system with 4 past producing gold mines and extensive underground workings. It has historic resources of up to 10-15 g/t Au. The Rio Mine is ready for reopening with 1,500m of underground workings.

This past March, Searchlight Resources announced that it received the final payment of $225,000 from the sale of the New York Canyon Property, NV to Emgold Mining Corporation, a company listed on the TSX Venture Exchange under the symbol “EMR”. Under the Agreement terms, Searchlight Resources will transfer all its interest in and to the New York Canyon Property to Emgold Mining and, in consideration of which, Emgold will have paid Searchlight CAD $275,000 and issued 2,941,176 common shares of Emgold.

This week, Searchlight Resources announced the appointment of Mr. Alf Stewart and Mr. Peter A. Ball to the Searchlight Board of Directors. Mr. Stewart, B.SC. Geology, MBA, has a career spanning more than 4 decades in the resource and investment industries. His career includes time spent as a geologist, stock exchange regulator, investment banker, analyst, and investment advisor.

Mr. Ball brings almost 3 decades of experience as a mining professional at all levels of leadership. Throughout Mr. Ball’s career, he has held different senior management roles with global precious metals mining companies in corporate finance, securities trading, mine engineering, business development, corporate communications, public relations, and marketing functions internationally.

Searchlight Resources, Inc. (CNYCF), closed Friday's trading session at $0.06, off by 6.3963%, on 68,604 volume with 8 trades. The average volume for the last 3 months is 59,400 and the stock's 52-week low/high is $0.002499999/$0.101999998.

TOMI Environmental Solutions, Inc. (TOMZ)

Streetwise Reports, MicroCapDaily, YCharts, TipRanks, Market Screener, The Stock Market Watch, Seeking Alpha, Stockopedia, OTC Markets, Business Wire, Simply Wall St, InvestorsHub, Pink Investing, hot Stocked, Dividend Investor, CSI Market, Morningstar, last10k, Nasdaq, Insider Financial, BioSpace, and Stockwatch reported beforehand on TOMI Environmental Solutions, Inc. (TOMZ), and today we report on the Company, here at the QualityStocks Daily Newsletter.

TOMI Environmental Solutions, Inc. is a global decontamination and infection prevention company based in Beverly Hills, California. TOMI provides environmental solutions for indoor surface disinfection through the manufacturing, sales, and licensing of its premier Binary Ionization Technology® (BIT™) platform. The Company develops training programs and application protocols for its clients. TOMI Environmental Solutions lists on the OTC Markets’ OTCQB.

The Company is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT™ solution uses a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol that works like a visual non-caustic gas.

The design of TOMI’s products are to service a broad variety of commercial structures. This includes, but is not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities. Furthermore, the Company’s products and services have been used in single-family homes and multi-unit residences.

Recently, TOMI Environmental Solutions announced that the demand for SteraMist BIT solution has surged. Since the beginning of the SARS-CoV-2 outbreak, SteraMist solution orders have increased considerably this year. The Company’s BIT solution sales have risen significantly throughout a number of divisions including Hospital-Healthcare, Life Sciences, and the TOMI Service Network (TSN). TOMI’s revenue model is heavily driven by recurring BIT solution usage by clients and service providers, providing a consistent and predictable revenue stream over time.

For the three months ended March 31, 2020 versus March 31, 2019, TOMI’s Total Net Revenue was $7,053,000 versus $1,253,000. This represents an increase of $5,800,000, or 463 percent. Net Income was $2,619,000, or $0.02 on a per share basis versus a Net loss of ($935,000), or ($0.01) on a per share basis. This represents an increase of $3,554,000, or 380 percent.

TOMI Environmental Solutions Chief Executive Officer, Dr. Halden Shane, stated, “In the beginning of 2020 the world saw a surge globally for disinfectants and an enhanced level of clean to help prevent and mitigate the spread of the SARS CoV-2 coronavirus, which has put TOMI and its SteraMist® line of products front and center in the fight against this global pandemic.”

TOMI Environmental Solutions, Inc. (TOMZ), closed Friday's trading session at $0.82, off by 7.3446%, on 2,237,696 volume with 1,056 trades. The average volume for the last 3 months is 1,325,998 and the stock's 52-week low/high is $0.061/$1.50999999.

Core One Labs, Inc. (CLABF)

Fortune420, Stockwatch, Stock Day Media, Nasdaq, Investing News, Dividend Investor, Market Screener, PR Newswire, Green Market Report, the deepdive.ca, InvestorsHub, Barchart, Stockhouse, GuruFocus, Investors Observer, BioSpace, Canadian Insider, TradingView, Newsfilecorp, Ceo.ca, Proactive Investors, InvestorX, and OTC Markets reported beforehand on Core One Labs, Inc. (CLABF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

A technology company, Core One Labs, Inc. licenses its technology to a state-of-the-art production and packaging facility located in Southern California. Its technology produces infused strips (like breath strips) that are a safer, healthier option to other forms of delivery. They also offer superior bioavailability of cannabis constituents. In addition, some strips will include supplemental co-active ingredients, including nutraceuticals, vitamins and peptides. The Company previously went by the name Lifestyle Delivery Systems, Inc. It changed its corporate name to Core One Labs, Inc. in September of 2019. Established in 2010, Core One Labs is based in Vancouver, British Columbia.

The Company’s focus is the California cannabis industry. It is a fully vertically integrated company in the largest cannabis market in North America. Core One Labs has expanding portfolios of proprietary technology and patent-pending intellectual property (IP), combined with a full complement of issued state and municipal permits and licenses. Furthermore, via its efforts to develop a better CannaStrips™ product, Core One Labs has developed substantial expertise in cannabis extraction and nursery activities.

The Company has the in-house expertise, capability and capacity to develop and control genetics, grow and mature cannabis biomass, extract and distill cannabinoid actives, manufacture innovative products with precisely controlled dosing, distribute wholesale and retail, and transport products across California. In complete compliance and with full documentation consistent with existing statutes and regulations, Core One Labs participates in every step, from seed to customer.

This past February, Core One Labs announced that its wholly-owned subsidiary, Core Isogenics, Inc., completed its seventh and eighth consecutive harvests at the Adelanto facility. The Core Isogenics nursery and cultivation team continue to demonstrate consistent execution completing eight multiple strain harvests in eight weeks.

The Company stated that Core Isogenics has proven capable of meeting timely deliveries and contract deadlines. Now that Core Isogenics' cultivation portion of the facility is fully operational, it commenced harvesting about 40-60lbs on a weekly basis to be sold in bulk or via its in-house brand Rêveur.

Recently, Core One Labs announced that, further to its news release dated February 11, 2020, it signed definitive agreements regarding a CDN$1,500,000 convertible debt facility with Cannabis Growth Opportunity Corporation (CGOC). Core One Labs issued to CGOC a convertible debenture in the principal amount of up to CDN$1,500,000 (Debenture) and 1,500,000 common share purchase warrants (Warrants). The aggregate principal amount available under the Debenture will be advanced by CGOC to Core One Labs in three equal installments of CDN$500,000 each.

Mr. Brad Eckenweiler, Chief Executive Officer for Core One Labs, said, "This new relationship with CGOC will open new opportunities for us in both California and Canada. We are very much looking forward to working with the CGOC team and applying their expertise to our current and future projects."

Core One Labs, Inc. (CLABF), closed Friday's trading session at $0.17056, up 62.4381%, on 38,373 volume with 26 trades. The average volume for the last 3 months is 17,735 and the stock's 52-week low/high is $0.085500001/$1.96200001.

Silex Systems Limited (SILXY)

Stockaholics, Penny Stock Hub, Speculating Stocks, Proactive Investors, Wallet Investor, OTC Markets, OTC.Watch, Investing.com, and 4-Traders reported beforehand on Silex Systems Limited (SILXY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Silex Systems Limited is a high-technology company based in Australia. It focuses on the delivery of the innovative and disruptive SILEX Laser Enrichment Technology as the next generation technology for the worldwide uranium enrichment industry. The Company invented and initially developed the ‘SILEX’ laser-based uranium enrichment technology in Sydney during the 1990’s. Silex Systems lists on the OTC Markets Group’s OTCQX.

The ‘SILEX’ laser-based uranium enrichment technology was licensed exclusively in 2006 to GE-Hitachi Global Laser Enrichment LLC (GLE). GLE is a business venture presently consisting of GE (51 percent), Hitachi (25 percent) and Cameco (24 percent). Silex and GLE jointly continue to commercialize the technology for potential deployment in the United States. Silex Systems scientists Dr. Michael Goldsworthy and Dr. Horst Struve invented the SILEX technology in the mid 1990’s at Lucas Heights, Sydney.

In essence, the SILEX technology is an inventive laser-based process. It has the potential to economically separate uranium isotopes as well as commercially valuable isotopes of a number of other elements. Its advantages over other uranium enrichment processes include inherently higher efficiency resulting in lower costs. Advantages also include a smaller environmental footprint than centrifuge and diffusion plants. Furthermore, it has greater flexibility in producing advanced fuels for next generation small modular reactors (SMR's). The SILEX technology is also expected to have the lowest capital costs of all enrichment technologies.

Silex subsidiary Translucent, Inc. developed a novel set of semiconductor materials known as ‘crystalline Rare Earth Oxides’ (cREO™). These are for application to the manufacturing of next generation semiconductor devices used in wireless communications, power electronics and other advanced semiconductor industries.

Silex Systems recently provided an update on its recent activities. Silex is working towards finalization of a binding purchase agreement for the restructure of SILEX technology licensee GE-Hitachi Global Laser Enrichment LLC (GLE). This follows the signing of a Term Sheet on February 5, 2019 that provides the key terms for a proposed joint purchase by Silex and Cameco of GE-Hitachi’s (GEH) 76 percent interest in GLE. Subject to obtaining U.S. Government approvals, the proposed restructure of GLE would result in Silex Systems acquiring a 51 percent interest, and Cameco increasing its interest in GLE from 24 percent to 49 percent.

Regarding the Translucent cREO™ technology and IQE, IQE Plc (LON: IQE), who acquired Translucent’s unique cREO™ semiconductor materials technology in March of 2018, disclosed on March 20, 2019 in the commentary to its full year results that positive progress continues to be made in the commercialization of cREO™ for application in many of its key target markets. A perpetual royalty of between 3 percent and 6 percent will be payable to Translucent on the sale of any IQE products globally that use the cREO™ technology, with minimum annual royalties due to start being paid in FY2020 for the first 6 years.

Silex Systems Limited (SILXY), closed Friday's trading session at $1.82, up 58.2609%, on 100 volume with 1 trade. The average volume for the last 3 months is 167 and the stock's 52-week low/high is $0.596199989/$2.06999993.

Serica Energy plc (SQZZF)

Wallet Investor, Invest Tribune, Dividend Investor, Market Screener, Seeking Alpha, Stockhouse, MarketWatch, Trading View, Wallmine, Investors Hangout, Pink Investing, The Street, 4-Traders, Guru focus, and Barchart reported earlier on Serica Energy plc (SQZZF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Serica Energy plc is an independent upstream oil and gas company headquartered in London, United Kingdom (UK). The Company has operations focused on the UK North Sea where it has the full range of exploration, development, as well as production assets. Serica’s primary emphasis is on building a portfolio of properties where it can use its technical, commercial and operating capabilities to add value to existing producing assets and to explore and develop new reserves. Established in 2004, Serica Energy lists on the OTC Markets.

Serica has proved the success of the above-mentioned model via its producing asset, Erskine, in which it is a partner with Chevron and Chrysaor. On November 30, 2018, the Company completed the acquisition of interests in the Bruce, Keith and Rhum fields where it also took over as field operator. These fields are a combination of late-life and mid-life, mainly gas producing assets where further investment can enhance recovery and extend field life.

The Bruce, Rhum and Keith fields in the UK Northern North Sea produce through the Serica operated Bruce facilities, consisting of three platforms with accommodation for up to 160 people. Serica Energy has drilled 23 wells since its inception in 2004, 17 as operator.

Serica has drilled wells across a broad spectrum of offshore geographies. This includes the UK, Ireland, Indonesia and Vietnam. As an operator, 14 of the 17 wells drilled by the Company encountered oil or gas, six of which were of commercial significance, leading to the discovery of Columbus in the UK North Sea and Kambuna in Indonesia.

Since its direct involvement in the Erskine operations, Serica Energy has contributed to a major improvement in the asset’s production levels. Serica is the development operator for Columbus. It also developed the Kambuna field before selling its operated interest on favorable terms to the Company in 2008.

Serica Energy plc (SQZZF), closed Friday's trading session at $1.606058, up 78.4509%, on 85,000 volume with 2 trades. The average volume for the last 3 months is 4,181 and the stock's 52-week low/high is $0.25/$1.61000001.

Wize Pharma, Inc. (WIZP)

Dividend Investor, Stockwatch, Capital Cube, Cardinal Weekly, Investors Hangout, Insider Mole, Stockopedia, Penny Stock Hub, Stockhouse, InvestorsHub, Wallmine, OTC Markets, Barchart, MarketWatch, and 4-Traders reported earlier on Wize Pharma, Inc. (WIZP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Wize Pharma, Inc. focuses on the treatment of ophthalmic disorders. This includes dry eye syndrome (DES). The OTCQB-listed Company previously went by the name Star Night Technologies Ltd. It changed its corporate name to Wize Pharma, Inc. in July of 2015. A clinical-stage biopharmaceutical enterprise, the Company is headquartered in Hod Hasharon, Israel.

Wize Pharma has in-licensed certain rights to purchase, market, sell, and distribute a formula named LO2A. This is a drug developed for the treatment of DES, and other ophthalmological illnesses, including conjunctivochalasis (CCH) and Sjögren's Syndrome. Currently, LO2A is registered and marketed by its inventor in Germany and Switzerland for the treatment of DES, in Hungary for the treatment of DES and CCH, and in the Netherlands for the treatment of DES and Sjögren's Syndrome.

Wize Pharma is now conducting a Phase II trial of LO2A for patients with CCH and a Phase IV study for LO2A for DES in patients with Sjögren's. The Company announced in March of last year that it enrolled the initial patient in its Phase IV clinical trial in Israel for LO2A in the symptomatic treatment of dry eye syndrome (DES) in patients with Sjögren's syndrome. This randomized, double-masked study is evaluating LO2A versus Alcon's Systane® Ultra UD, an over-the-counter (OTC) lubricant eye drop product used to relieve dry and irritated eyes.

The design of the study (in addition to meeting marketing approval requirements in Israel) is to support Wize Pharma’s clinical approval pathway for LO2A for the treatment of DES in patients with Sjögren's in other markets including the U.S., China, and Ukraine. LO2A is already approved in Israel for the treatment of DES.

This past November, Wize Pharma announced top line results from its Phase II clinical trial in Israel of LO2A for the symptomatic treatment of dry eye syndrome (DES) in patients with moderate to severe conjunctivochalasis (CCh). Wize Pharma's Chairman, Noam Danenberg, stated, "We are very pleased with these top line results and we look forward to analyzing the full results. We believe the full results from this study, will support our clinical development path and provide firm basis for presentation and discussions with the FDA for the approval pathway of LO2A in the U.S. and additional countries."

Recently, Wize Pharma announced that it signed an agreement with Cannabics Pharmaceuticals, Inc. (OTCQB: CNBX) to form a joint venture (JV) company for researching, developing and administering cannabinoid formulations to treat ophthalmic conditions. Cannabics Pharmaceuticals is a global leader in personalized cannabinoid medicine centered on cancer and its side effects.

This agreement will become effective subject to receipt of an expert opinion, within 30 days from the date of signing, describing the regulatory pathway for eye drops containing cannabinoids. Upon effectiveness, Wize Pharma shall issue 900,000 shares of its common stock to Cannabics Pharmaceuticals. Cannabics shall issue 2,263,944 shares of its common stock to Wize. This agreement will expire if the parties have not approved a business plan by June 30, 2019.

Wize Pharma, Inc. (WIZP), closed Friday's trading session at $0.25, up 70.068%, on 8,395 volume with 7 trades. The average volume for the last 3 months is 22,068 and the stock's 52-week low/high is $0.061/$0.680000007.

Kalytera Therapeutics, Inc. (KALTF)

Penny Stock Hub, Dividend Investor, Proactive Investors, YCharts, Capital Network, OTC.Watch, Investing, The Street, OTC Markets, InvestorsHub, 4-Traders, Stockhouse, Stockwatch, Marketbeat, Investors Hangout, and Barchart reported earlier on Kalytera Therapeutics, Inc. (KALTF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Kalytera Therapeutics, Inc. is pioneering the development of a next generation of cannabinoid therapeutics. The Company is working to establish a leading position in the development of novel cannabinoid medicines for an array of important unmet medical needs, with an initial focus on Graft versus Host Disease (GvHD). Kalytera Therapeutics has its U.S. headquarters in Novato, California. A clinical-stage pharmaceutical company, its research facility is in Israel.

Kalytera Therapeutics is also developing a new class of proprietary cannabidiol (CBD) therapeutics. Its intention is to explore the use of CBD, a non-psychoactive cannabis constituent. The Company is working to advance a portfolio of synthetic, non-psychoactive cannabis-like molecules. Additionally, Kalytera will center on orphan conditions, with the aim of generating data in humans that may support follow-on studies in major conditions.

Kalytera received approval from the Institutional Review Board (IRB) at one of two clinical sites in Israel. This is to begin a Phase 2 study to evaluate cannabidiol (CBD) for the prevention of GvHD. The proposed study is a Phase 2, open label, multicenter trial. The trial is to evaluate the pharmacokinetic profile, safety, and efficacy of numerous doses of CBD for the prevention of GvHD following allogeneic hematopoietic cell transplantation (HCT). The proposed study will take place at the Rabin Medical Center, Beilinson, and the Rambam Health Care Campus, Haifa, in Israel.

The expectation is that Kalytera’s continuing Phase 2b clinical study evaluating the use of CBD in the prevention of GVHD will be completed early this year. Upon completion of the Phase 2b clinical study, Kalytera will begin preparations for the pivotal Phase 3 clinical study that will be required for Food and Drug Administration (FDA) approval.

The work that Kalytera Therapeutics is doing in GVHD consists of two separate product development programs. One is a program evaluating CBD for the prevention of acute GVHD. A separate program is evaluating CBD for the treatment of acute GVHD. The Company’s program in prevention of acute GVHD is more advanced than is the program in treatment of acute GVHD.

Kalytera Therapeutics is the exclusive licensee of two issued U.S. patents covering the use of CBD in the prevention and treatment of GVHD. It is also the exclusive licensee of pending patent applications in other jurisdictions for the use of CBD in the prevention and treatment of GVHD.

Recently, Kalytera Therapeutics announced positive interim data from its continuing Phase 2 clinical study evaluating cannabidiol (CBD) for the prevention of acute graft versus host disease (GVHD) following bone marrow transplant. Interim data from the initial 12-patient cohort support the following key findings to date.

No patients receiving oral CBD at the lowest study dose of 75 mg twice daily (BID) have developed grades 3 or 4 acute GVHD. One patient developed grade 2 acute GVHD, the least serious form of the disease. CBD has demonstrated a good safety and tolerability profile, with no significant adverse events relating to its use.

Kalytera Therapeutics, Inc. (KALTF), closed Friday's trading session at $0.0269, up 63.0303%, on 709,036 volume with 30 trades. The average volume for the last 3 months is 171,370 and the stock's 52-week low/high is $0.000099999/$0.254000008.

Firstgroup plc (FGROY)

Zacks, OTC Research, Amigo Bulls, Proactive Investors, OTC Markets, The Street, Marketbeat, TradingView, Investors Hangout, InvestorPoint, Wallmine, GuruFocus, Investing.com, Penny Stock Tweets, 4-Traders, Stockhouse, Wallet Investor, YCharts, Barchart, Dividend Investor and MoneyHub reported on Firstgroup plc (FGROY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Incorporated in 1995, Firstgroup plc provides passenger transport services. The Company has extensive experience in the United Kingdom bus and rail markets, and in the student transportation, transit and intercity coach markets in North America. Each of its businesses has a market-leading position in a sector that is key to boosting economic growth and vital to creating strong and sustainable communities. Firstgroup lists on the OTC Markets and the Company has its head office in London, England.

Firstgroup serves a large range of passengers in the United Kingdom and North America. In addition, the Company works with national governments, state and local authorities, school boards and universities to meet their transport requirements.

Firstgroup has 100,000 employees across the Group and it carries 2.1 billion passengers a year. The Company operates, manages or maintains combined fleets of 50,000 vehicles. Firstgroup has five divisions.

The Company’s Greyhound is the only national operator of scheduled intercity coach services in North America. Greyhound serves 17 million passengers a year. Greyhound has 1,600 vehicles in its fleet.

Moreover, Firstgroup’s First Bus is one of the largest bus operators in the United Kingdom. First Bus serves towns and cities across the country. First Bus has 5,800 buses and serves 1.6 million passengers per day.

First Rail is one of the United Kingdom’s most experienced rail operators. It runs every kind of service from Cornwall to Scotland. First Rail operates more than 400 stations. It operates three United Kingdom rail franchises - Great Western Railway, South Western Railway and TransPennine Express. It also operates one open access passenger rail service, Hull Trains. Furthermore, it operates the London Trams service on behalf of Transport for London.

The Company’s First Student is the largest provider of student transportation in North America. First Student has greater than 460 operating locations throughout the United States and Canada. It engages in five million student journeys per school day.

The Company’s First Transit is one of the largest private sector providers of public transit management and contracting in North America. First Transit has over 310 operating locations throughout the United States and Canada. It owns or operates greater than 12,600 vehicles and maintains a further 35,000.

Firstgroup plc (FGROY), closed Friday's trading session at $0.995, up 51.9084%, on 100 volume with 1 trade. The average volume for the last 3 months is 2,840 and the stock's 52-week low/high is $0.382999986/$1.77999997.

Sunset Island Group, Inc. (SIGO)

MicrocapVoice, PennyStockSpy,  OTCPicks,  and 007 Stock Chat reported earlier on Sunset Island Group, Inc. (SIGO), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Sunset Island Group, Inc. provides consulting and advisory services to clients operating in the medical marijuana business space.  The Company concentrates on providing a licensed manufacturing facility to clients for producing products, including oils and edibles. Sunset Island Group has its corporate office in San Clemente,  California.

The Company’s vision is to establish a fully integrated business, which provides turnkey solutions to the medical cannabis industry. Its primary emphasis is on providing a licensed facility where companies can manufacture and produce their products. In addition, Sunset Island will provide distribution for companies via an established network of dispensaries.

Sunset Island Group earlier secured a lease on a property approved for cannabis cultivation. The Company for permits for 22,000 square feet of green house space. The expectation is that the 22,000 square feet of green house space will be able to produce up to 4,000 pounds of medical cannabis each year. 

Sunset Island announced last year that it initiated development of a CBD dietary supplement product. The initial product will feature a 2-oz stress relief beverage made from highest quality legal Hemp/CBD oil and real fruit.

Sunset Island will continue to develop products that will address the demands in the worldwide dietary supplements market. This market is targeted to soon reach greater than $200 billion.  The product will undergo development by a trained French Chef with more than two decades of experience in Product Development and Food Production.

Sunset Island Group is performing a retrofit to its current grow space that will considerably increase the amount of cannabis product produced with each harvest. Furthermore, the Company announced in November 2017 that it commenced an aggressive expansion of its cannabis product line.

The Company’s retro fit is two phases. Phase 1 is the retro fit of the present greenhouse operations. Phase 2 is the constructing of a new greenhouse on its bare land or retrofitting another greenhouse on the property.

The aim of the retro fit for Phase 1 is to increase the growable space in the current greenhouse to about 22,000 (with a vertical grow) with roughly 85 percent being canopy space (or around 19,000 square feet). The Company's objective is to yield 0.08-0.10 pounds per growable space and to have five harvests.

Sunset Island Group has received its temporary licenses from the State of California for Distribution, Cultivation and Manufacturing. The licenses are for Adult Use (Recreational) and Medicinal. The licenses permit Sunset Island to sell and transport its own product to dispensaries across California.

The manufacturing license allows it to start manufacturing products such as vape cartridges, edibles, as well as extracts. At present, Sunset Island is in the process of converting one of its cold storage rooms into a clean room to commence manufacturing these products.

Sunset Island Group, Inc. (SIGO), closed Friday's trading session at $0.10, up 53.8462%, on 11,835 volume with 6 trades. The average volume for the last 3 months is 6,582 and the stock's 52-week low/high is $0.023/$0.300000011.

The QualityStocks Company Corner

PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA)

The QualityStocks Daily Newsletter would like to spotlight PowerBand Solutions Inc. (TSXV: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA).

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) recently secured an additional $600,000 from Texas-based D&P Holdings Inc. to offer its platform that provides virtual transactions to consumers and automotive dealers in the United States. To view the full article, visit http://nnw.fm/BC5qh

A Better Way to Connect and Acquire Vehicles

PowerBand’s mission is to create an online, consumer-directed marketplace that streamlines the interactions among all participants in the automotive industry. It transforms today’s antiquated business model with speed, transparency, access to information and ease of use for consumers and dealers.

Consumers can easily connect with new sources to buy vehicles, network with motivated buyers and sellers, maximize their trade-in values, improve their customer experience. PowerBand’s standardized system and transaction process also increase efficiencies and benefits with hands-on, process-driven, in-store training and support.

Through internal development, acquisitions, joint ventures and strategic partnerships, PowerBand is developing solutions for consumers, dealers, manufacturers, commercial customers and lenders that are poised to transform the trillion-dollar U.S. automotive industry.

The PowerBand Auto Platform

PowerBand’s transaction platform was developed by a team of experienced automotive, technology and finance experts, and has been refined through years of operational experience. Built on the core belief that the consumer prefers to primarily conduct automotive transactions online and avoid interactions with unnecessary middlemen, PowerBand’s product solutions include:

  • Leasing: PowerBand is currently licensed in 33 U.S. states via a majority interest in MUSA Auto Finance LLC, an advanced online leasing technology platform that has transformed the new and used vehicle leasing industry. A partnership with Tesla was recently finalized, making MUSA the only approved, non-captive lease partner for Tesla in the U.S.
  • Inventory and Financing: A partnership with RouteOne LLC, a leading financial platform founded in 2002 by Ally Financial, Ford Motor Credit Co., TD Auto Finance and Toyota Financial Services, allows access to a network of more than 18,000 dealerships and 1,400 financing sources.
  • Auction Platform: PowerBand and its joint-venture partner, D2D Auto Auctions, are developing a direct consumer-to-dealer and a consumer-to-consumer automotive portal, which will provide an innovative alternative to physical dealership and auction locations.
  • LiveNet Auction: An online platform portal that allows dealers to create instant live vehicle auctions to a vast network of the industry’s top used vehicle buyers.
  • MarketPlace Auction: An online listing auction site for buying and selling automotive inventory – ideal for dealers, fleet, OEM and rental companies.
  • Used Vehicle Inspections: An LOI agreement with TÜV NORD Mobility Inc., a German-based global leader in vehicle inspections operating in more than 70 countries, will provide the most comprehensive, certified vehicle inspection reports available in North America. Appointments booked within the platform can be performed nearly anywhere.
  • Product Development: PowerBand’s comprehensive consumer solution, Driveaway, will be a fully transactional consumer marketplace where dealers and consumers can buy, sell, trade-in and finance vehicles, often in seconds, from the comfort of their home.

Automotive’s Growing Markets

The automotive dealership and commercial fleet vehicle auction industry is a $100-billion sector with more than 40 million used vehicles transacted in the U.S. each year. Of those, ten million are sold through auctions. From 2013 to 2017, the growth of online-only auctions far outpaced physical auctions, growing at a 33% compound annual growth rate compared to 2% CAGR at physical auctions.

Automotive leasing is another large, growing and fragmented market, generating approximately $120-billion in annual revenue. As a percentage of vehicle sales, leasing reached 30% in 2018, up from 21% in 2012, and is seen as a substantial opportunity for PowerBand and MUSA Auto Finance. Using proprietary technology and by focusing on high-quality, credit-worthy customers, MUSA grew its automotive lease originations to $182 million.

Disrupting Auto Leasing with MUSA

Legacy solutions are complicated, expensive and slow at processing leases. MUSA’s first-of-its-kind technology platform eliminates third-party decisions and the human capital required in the underwriting process. MUSA’s platform navigates the entire customer experience – underwriting, funding and the delivery process – within minutes. Leases can be approved in seconds.

PowerBand’s acquisition of MUSA brings together two leading-edge companies with the vision to become a one-stop platform for the entire vehicle purchase lifecycle.

Experienced Leadership

PowerBand is led by a collection of automotive veterans with a passion to collectively and positively impact the industry.

  • Kelly Jennings, president and CEO, is the founder of PowerBand Solutions and a franchise dealer owner/operator with more than 27 years of automotive experience. Jennings received General Motor’s Triple Crown Award, Ford Motor Company President’s Award and Honda Canada’s Excellence Award.
  • Darrin Swenson, COO of PowerBand and D2D Auto Auctions/Hunt Automotive Group, has more than 25 years of automotive/auction experience.
  • Jeff Morgan, CEO MUSA, holds over 25 years of experience in the auto finance sector.

 

PowerBand Solutions Inc. (OTCQB: PWWBF), closed Friday's trading session at $0.181, up 23.1293%, on 300,993 volume with 36 trades. The average volume for the last 3 months is 46,313 and the stock's 52-week low/high is $0.038600001/$0.230000004.

Recent News

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (SGMD) was featured today in the 420 with CNW by CannabisNewsWire. The state of Maine is being sued by local marijuana businesses for refusing to enforce a component of its marijuana laws. On Friday, the Maine Cannabis Coalition filed a lawsuit against the state, claiming that the Department of Administrative and Financial Services was in violation of state law after it failed to enforce the residency requirements included by lawmakers in the Marijuana Legalization Act.

Sugarmade, Inc. (SGMD) is headquartered in Monrovia, California, where the company recognizes new opportunities in the cannabis delivery space and in the market for supplies to the quick-service restaurant industry – both of which have fast-changing dynamics due to the recent outbreak of coronavirus in the United States.

The Coronavirus Cannabis Boom Market

Retailers across the nation are closing their doors and curtailing operations due to the coronavirus pandemic, inherently pinching sales. In the California cannabis sector, however, business has never been better – especially relative to home delivery.

California’s cannabis industry continues to operate, and media reports reveal booming cannabis sales as the state’s citizens stay home to wait out current events. The Los Angeles Times recently published the headline, “Marijuana Sales on Fire amid Virus Outbreak; New York Post “Cannabis sales hit new highs”; USA Today “American Stock Up on Pot” Fox News “California marijuana sales surge”; and ABC News Cannabis Shops thrive in coronavirus pandemic.

The state of California benefits from the ultra-high taxes paid by the highly regulated cannabis industry, and has thus deemed cannabis companies as “essential” businesses, allowing for full operations to continue. While pot shops are seeing strong foot traffic, the real growth action is in-home delivery as consumers seek to embrace social distancing. Many delivery operators are reporting difficulty in meeting demand with sales growth of up to 10% sequentially each week. It is certainly a boom time for the industry.

Sugarmade Growth Strategy

Recognizing new investment and operational opportunities within California’s cannabis market, Sugarmade is strategizing to take advantage of opportunity specifically in delivery services (non-storefront retailer), manufacturing via co-branding, and selective genetic cultivation. The company is taking a highly selective approach, targeting only the best of these opportunities for company growth.

In line with this strategy is northern California delivery service Budcars, in which Sugarmade owns a 40% interest and an option to gain a controlling interest. Budcars connects consumers with premium products sourced from top-tier farms and extractors, offering a curated menu of fully compliant cannabis products. The company maintains a competitive advantage by sourcing premium cannabis offerings and same-day delivery. In addition to maintaining its own cars, California licenses, and fulfillment center, Budcar orders its premium products in bulk at lower prices, enabling the company to rein in costs and maintain competitive pricing for its customers. Currently serving major communities within the metropolitan area of Sacramento, Budcars plans to continue the expansion of the company’s delivery reach.

Sugarmade plans to continue its expansion into burgeoning new sectors of the cannabis market through the following avenues:

  • Geographic expansion of Budcars delivery scope
  • New delivery geographies
  • Cannabis cultivation as a key component of a hybrid vertical integration strategy
  • Product technology expansion—including products containing exotic and lesser-known cannabinoids

 

Diversified Portfolio

Sugarmade has positive market exposure to cannabis delivery, as well as to the restaurant industry, at a time when these businesses are being force to move toward take-out and delivery models in order to survive.

The company has various business operations in diverse marketplaces, including food, safe packaging and sanitary supplies for various industries, and agricultural supplies. Sugarmade entered the industrial hemp and CBD space by investing in Hempistry, Inc., a privately held Nevada corporation. Hempistry began planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 5,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3% of THC, the psychoactive ingredient found in cannabis.

CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high-quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30%-40% of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Market Opportunity

There is little doubt among industry participants, and recently confirmed by Forbes, that California is the single largest cannabis market in the world. The state is expected to produce more than $3.5 billion in cannabis sales during 2020, with growth topping 23% annually. The global industrial hemp market size was estimated at $4.71 billion in 2019 and is expected to register a revenue-based CAGR of 15.8% over the forecast period of 2016-2027, according to Grandview Research. Market growth drivers include the 2018 Farm Bill and society’s increasing knowledge of the benefits of hemp products.

Overall industry growth is great, but specific vertical sector growth is even better. Cannabis delivery is clearly the fastest growing sector of the marketplace and with coronavirus fears the already robust growth rate has accelerated.

Sugarmade seems to be in the right industry at the right time in history.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick-service restaurant industry, which merged with Sugarmade in 2014.

Dedicated to getting the highest caliber of THC and CBD to its customers’ door, the company’s priority is to ensure that they receive the highest quality cannabis product free from logistical hassles. Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed Friday's trading session at $0.002, up 5.2632%, on 88,532,305 volume with 275 trades. The average volume for the last 3 months is 25,175,688 and the stock's 52-week low/high is $0.001649999/$0.050500001.

Recent News

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs (NASDAQ: SGLB), a leading developer of quality assurance software for the additive manufacturing industry, today announced that, due to the current impact of the COVID-19 pandemic and limitations within the state of New Mexico on all non-essential gatherings of individuals, it has changed the format of its annual stockholders meeting. According to the update, the 2020 meeting will be in the format of a virtual webcast, and Sigma Labs invites stockholders to participate remotely. The meeting is scheduled to take place at 10:00 a.m. Mountain Time on June 15, 2020. Interested parties may register to attend at http://nnw.fm/vZ5YJ. To view the full press release, visit http://nnw.fm/3gLq3.

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Friday's trading session at $2.67, off by 2.1978%, on 296,140 volume with 1,173 trades. The average volume for the last 3 months is 517,043 and the stock's 52-week low/high is $1.97000002/$17.00.

Recent News

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

In late 2014, UK cell provider Three introduced its award-winning ‘Holiday Spam’ campaign, promoting the mobile company’s roaming data offering which enabled customers to use their phones abroad at no extra cost (http://nnw.fm/6nIhv). The ad campaign featured people ‘spamming’ their friends with their holiday snaps, a concept which resulted from the company’s costly and painstaking investigation into people’s behavior while on vacation – a form of research which SRAX Inc.’s (NASDAQ: SRAX) proprietary BIGtoken platform has now appropriated into an efficient and accessible service offering. The rise of data-driven marketing and the ability to personalize and launch targeted ad campaigns has become critical in improving ad content quality and driving customer engagement. 

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Friday's trading session at $1.99, off by 1.4803%, on 25,791 volume with 179 trades. The average volume for the last 3 months is 56,882 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) was featured today in the 420 with CNW by CannabisNewsWire. On May 25, 2020, George Floyd, a black man, died at the hands of a Minneapolis Police Department officer, leading to nationwide protests against systemic police brutality against unarmed black men. Although the protests were peaceful at first, they became violent, leading to widespread rioting and looting over the weekend. Tons of business establishments nationwide have been affected by the looting, and marijuana businesses haven’t been spared.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Friday's trading session at $0.61, off by 4.6875%, on 58,579 volume with 75 trades. The average volume for the last 3 months is 36,754 and the stock's 52-week low/high is $0.279000014/$4.03999996.

Recent News

National Storm Recovery Inc. (OTC: NSRI)

The QualityStocks Daily Newsletter would like to spotlight National Storm Recovery Inc. (NSRI).

National Storm Recovery (OTC: NSRI), a leading provider of environmentally beneficial solutions for tree and storm-waste disposal, has three substantial agreements in place as it gets ready for the 2020 storm season. To view the full article, visit http://nnw.fm/1u98Q

National Storm Recovery Inc. (OTC: NSRI), through its subsidiaries, including National Storm Recovery, LLC (DBA Central Florida Arbor Care and Mulch Manufacturing, Inc.), provides tree services, debris hauling, removal and bio-mass recycling, manufacturing, packaging and sales of next-generation mulch products. The company’s primary corporate objective is to provide a solution for the treatment and handling of tree debris that is historically sent to local landfills and disposal sites, creating an environmental burden and pressure on disposal sites around the nation.

Environmentally Friendly

National Storm and the solutions provided by its Sustainable Green Team are founded in sustainability. The company’s vertically integrated operations begin with the collection of tree debris through its tree services division and collection sites. Tree bio-mass is then moved through the processing division for recycling and manufacturing into a variety of organic, attractive, next-generation mulch products to be packaged and sold to retailers, landscapers, installers and garden centers.

The company’s solutions create a synergistic and environmentally beneficial solution to tree and storm waste disposal that historically has created an environmental burden on landfills and disposal sites around the nation.

National Storm’s customers include governmental, residential and commercial customers and now big box retailers. The company is headquartered in Florida.

Strategic Acquisition

National Storm in February 2020 acquired 35-year-old industry leader and innovator Mulch Manufacturing, Inc., an Ohio corporation. Structured as a share exchange, this strategic partnership provides National Storm with a significantly larger footprint in the mulch industry.

The acquisition includes Mulch Manufacturing’s national and international distribution agreements, an increase in production and packaging capacity, and its sales contracts with numerous big box retailers. Mulch Manufacturing includes mulch production, sawmill operation, Natures Reflections colorant manufacturing and equipment manufacturing.

Next-Gen Products

National Storm’s vision and commitment to the environment is paired with Mulch Manufacturing’s revolutionary “next-generation” mulch product, Nature’s Reflection’s Softscape®.

Softscape mulch products, created from natural forest products, are color-enhanced with environmentally safe colorants to provide four-year color retention and are free from contaminants. Safe for people and pets, Softscape allows water and air to penetrate soil and roots, which is vital to plant health and growth.

Expansion Plans

National Storm plans to expand its operations through a combination of organic growth, through its partnership with a nationally recognized waste disposal company, and through strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified.

The company has received final zoning approval for its 100-acre site, located in Lake County, Astatula, Florida, which will serve as the company’s flagship tree debris collection site. The facility will also house the company’s mulch manufacturing, soil composting and production bagging. This prime location includes a 5,000-square-foot building that contains warehouse and office space. The 100-acre property can accommodate millions of cubic yards of organic debris and will allow National Storm’s debris hauling division to realize significant savings on its transportation costs.

National Storm has chosen as its new headquarters the Mulch Manufacturing 100,000-square-foot building in Jacksonville, Florida. The facility comprises centralized operations of Mulch Manufacturing, Inc. and National Storm Recovery, LLC, and has ample room to expand as the needed.

Leadership

National Storm’s Sustainable Green Team boasts more than 40 years of next-level experience with mulch manufacturing, treating and caring for trees. This team is guided by a roster of highly qualified professionals:

  • Tony Raynor, Chief Executive Officer
  • Edward Lee, Chief Operating Officer
  • Ralph Spencer, Director of Business Development, Strategic Acquisitions
  • Steve Ogden, ISA-Certified Arborist
  • Rick Starcher, Master Chemist
  • Peder K. Davisson, Esq., Corporate/Securities Counsel

National Storm Recovery Inc. (OTC: NSRI), closed Friday's trading session at $0.53, off by 24.2857%, on 2,850 volume with 5 trades. The average volume for the last 3 months is 949 and the stock's 52-week low/high is $0.05/$3.00.

Recent News

ISW Holdings (ISWH)

The QualityStocks Daily Newsletter would like to spotlight ISW Holdings (ISWH).

International Spirits & Wellness Holdings (OTC: ISWH) (“ISW Holdings”), a top-tier brand incubator operating in the spirits, CBD-infused products, and home healthcare markets, recently announced the expansion of its home healthcare segment to multiple new major metropolitan areas in Nevada, New Mexico, Arizona and Florida. To view the full press release, visit http://nnw.fm/Sw0So

ISW Holdings (ISWH) (“ISW Holdings”) is a brand management portfolio company with diverse partnerships that focus on growing businesses in multiple sectors, including crypto mining, renewable energy, home health care for the chronically ill, wellness and restoration, and the adult beverage industry, as well as early-stage operations in supply chain and logistics management. ISW Holdings operates as the nexus between its partnerships and their essential services for end users.

Mission
The company’s core mission is to enhance these sectors by implementing innovative services and products ready to meet the demands of a changing world. To that end, ISW Holdings leverages its strategic expertise, resources, and innovative software to establish market-leading companies and partnerships, which ensure their success in their chosen industries. This enables the company to return maximum shareholder value with its focus always on its partnerships’ various sector volatility.

The Revolution
Positioned to create industry leaders, the company’s process entails strategic development and aggressive early growth of its partner brands to establish them as profitable and viable. ISW Holdings’ method is to nurture emerging partner brands through the essential stages of market development (from conceptualization to distribution) in sectors relevant to today’s marketplace. In addition, the company has a holistic approach to business development, with every strategy being delivered person-to-person from developers to end users.

The Challenge
The company’s goal is to turn its target audience into loyal consumers by ensuring transparency and a clear understanding of its products and services, thus creating visibility, credibility, and trust.

ISW Holdings’ Innovative Approach
ISW Holdings has diversified positions in its partnerships across technology, health care, wellness, renewable energy, and the adult beverage sectors. The company seek to provide industry leading modern solutions to its clients and sound business practices to its partners. This is accomplished through an early growth platform that cultivates its partnerships with the necessary resources and expertise to expand exponentially.

ISW Holdings’ Opportunity
The company’s opportunity is considerable. In the ever-changing high demand global marketplace, the need for timely innovation is critical. ISW Holdings’ portfolio brand management and creative thinking has allowed the company to develop and deploy enterprises that meet the needs of 21st century consumers. Through a fully vetted system of scalability, it is able to meet consumer demands with turn-key solutions.

Portfolio of Partnerships and Businesses
ISW Holdings’ diverse portfolio reflects the growing demand for essential services in a dynamic modern operational landscape. With partnerships that incorporate a depth of experience and industry insight, ISW Holdings has established itself as a portfolio company in technology, home health care, and wellness, with a focus on reshaping industry benchmarks.

Bit5ive

ISW Holdings operates a joint venture with Bit5ive, a global leader in cryptocurrency mining. As an official distribution partner of Bitmain (the industry’s leading fabless manufacturer of computing chips and distributor of Antminers to more than 30 countries in Latin America, Central America, and the Caribbean), Bit5ive is quickly becoming one of the largest U.S.-based companies in the cryptocurrency mining and bitcoin farm sectors of the market.
Valued at $293.66 million in 2019, the bitcoin technology market is expected to reach $477 million by 2025, according to Mordor Intelligence. The joint-venture agreement enables ISW Holdings to collaborate with the experienced team at Bit5ive to innovate the infrastructure needed to run profitable and efficient crypto mining projects.

Proceso, LLC

With a growing awareness of the importance of renewable energy worldwide, ISW Holdings has partnered with Proceso, LLC to create high-density processing and mobile data centers powered by renewable energy. These innovations will allow Proceso to offer lower-cost and diverse services to its clients, including hosting and colocation services to growing sectors such as the gaming industry and cryptocurrency mining – two fields with a typically high energy demand.

Because crypto mining companies mostly operate outside of the United States with higher asset security risks, Proceso will assist these entities in securing their investments by providing a local source of power and infrastructure development. This is aimed at helping to reduce power consumption while creating secure crypto mining data centers in the U.S. For the gaming industry, Proceso is ready to tackle one of its biggest problems, latency, by building next-level infrastructure in key locations.

PHH – Home Health

PHH Paradigm Home Health answers the growing need for homecare services in a world where health care delivery is changing and an increasingly large aging community is looking for efficient and effective ways of accessing health care. PHH aims to be at the forefront of this change by offering quality care services infused with new emerging technologies.

ISW Holdings’ home health division is currently developing a pilot for on-demand health care, which consists of a dedicated, stable platform for different medical services. The platform will offer greater freedom of choice and transparency by allowing users to find outpatient clinics in their vicinities, compare costs, and pick the most suitable choices. PHH is also developing specialized technology and tools to support health care services outside of the bounds of specialized facilities by focusing on homecare facilities. This can not only shift the burden from hospitals and clinics, but also streamline specific parts of the health care process to enhance service and product distribution.

VOLUM

ISW Holdings’ logistics and supply chain management division was designed with the core goal of increasing supply chain efficiency as one of the key aspects of successfully growing any business. The VOLUM project’s focus is on identifying and then implementing advanced supply chain management strategies and methods that will enable ISW Holdings’ partner companies to scale and grow exponentially. To achieve this goal, the company develops and offers reliable systems and solutions that create innovative technologies and unmanned system operations for overall higher cost-effectiveness.

In the wellness sector, ISW Holdings has opted for a two-pronged approach to create effective, technologically advanced products, as well as developing innovative ways to educate customers about these products. To this end, ISW Holdings has partnered with BioPulse to achieve state-of-the-art research and development and production capabilities, as well as a direct route to market. The company plans to design and launch up to five unique brands in the wellness and restoration sector in 2020.

ISW Holdings is committed to developing product and service innovation in the consumer spirits and adult beverage industry, which faces increasingly strict regulations but growing demand. The company has been a key innovator in the industry for 25 years, having grown successful luxury brands such as Besado Tequila and others. By leveraging its expertise, ISW Holdings can help companies in the adult beverage industry increase production, streamline their supply chains, implement better processes, innovate their marketing strategies, expand into new areas, and build sustainable relationships with partners and customers.

Management Team

Terry Williams, Chief Executive Officer and Director
Terry Williams brings to the company more than 30 years of experience in accounting and information systems, logistics, insurance, and transportation. With a Bachelor’s and Master’s degree in accounting and management information systems, Williams amassed considerable corporate experience at United Parcel Service, where he took several logistical roles, including controller, where he managed more than 2,000 employees and a budget of more than $10 billion.

Williams also serves as president of Airwave Transportation and logistics and chief financial officer of AVI Insurance Caribbean, and he has worked in over 37 domestic and international airports. In 2013, he received the National Airport Minority Advisory Council Award for mastering skills in the aviation industry.

Alonzo Pierce, Chairman
Alonzo Pierce is chairman of ISW Holdings and brings a wealth of business development and wealth management experience to the ISW team. He has spent the past 20 years building recognizable brands in multiple industry sectors. He has launched enterprises in life-styled brands which were delivered to high-profile, high-net worth families and individuals. He has worked in the adult beverage industry, establishing a formidable background in marketing and brand creation. Pierce has a B.A. from Baylor University and has received multiple awards in the adult beverage industry, including ‘Outstanding Sales Performance in the Southern Region’ for Sapphire Brands, including selling the world’s only black vodka. He served as regional director for Sapphire Brands, covering the Southwest and Southeast regions. Pierce also served as a national liaison to a Super-Regional Bank’s private wealth division. In addition to his for-profit endeavors, Pierce has served on multiple charitable boards, sourcing funding for JRA, food insecure families and housing insecure families.

Kristina Mahoney-Brown, Secretary, Treasurer, Director
Kristina Mahoney-Brown is secretary and treasurer as well as director of ISW Holdings. With more than 20 years of experience providing tax and financial consulting to real estate companies, as well as investors, developers and construction companies, Mahoney-Brown has gained solid business expertise and market knowledge and prides herself on staying abreast of the latest industry trends. Her professionalism, impeccable work ethic and advanced marketing strategies have earned her the nickname ‘The Tax Diva’. Mahoney-Brown has a Bachelor’s in accounting, a Master’s in taxation and a Master’s in business administration, specializing in personal financial planning.

ISW Holdings (ISWH), closed Friday's trading session at $0.23, off by 4.1667%, on 8,317 volume with 17 trades. The average volume for the last 3 months is 10,908 and the stock's 52-week low/high is $0.109999999/$17.00.

Recent News

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that it has started developing a mass screening solution for the detection of COVID-19 symptoms based on visible-light and thermal cameras. According to the update, the Company has submitted a patent application to the U.S. Patent and Trademark Office for a system and method for detection of people infected with COVID-19. To view the full press release, visit http://nnw.fm/VW3q2. Also today, the company was highlighted in a publication from MarketWatch, examining how FRSX shares more than doubled in premarket action.

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed Friday's trading session at $1.10, up 21.2255%, on 55,833,299 volume with 132,770 trades. The average volume for the last 3 months is 1,629,134 and the stock's 52-week low/high is $0.460999995/$2.94000005.

Recent News

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) was highlighted in a publication from MarketWatch, examining how CBD is not only a fast-growing repeat business for existing customers, a survey reported in site omnisend shows that some 40% of American consumers aged 21 and higher claim they would consider trying CBD. 

Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Friday's trading session at $0.2434, up 1.4167%, on 418,731 volume with 216 trades. The average volume for the last 3 months is 629,468 and the stock's 52-week low/high is $0.101000003/$1.39999997.

Recent News

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (OTCQB: CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households and more than 75 countries, covers money-focused topics and features in-depth interviews with CEOs and executives offering insights into various companies and their operations and future outlooks. To view the full press release, visit http://cnw.fm/a8dF6

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Friday's trading session at $0.0739, off by 1.4667%, on 107,988 volume with 26 trades. The average volume for the last 3 months is 56,585 and the stock's 52-week low/high is $0.052499998/$0.469999998.

Recent News

Trxade Group Inc. (NASDAQ: MEDS)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (NASDAQ: MEDS).

Trxade Group Inc. (NASDAQ: MEDS) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade’s overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company’s pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, “E-Bay/Kayak-like” technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the “consumer side” of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called “Delivmeds” (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade’s Managed Services Organization (“TrxadeMSO”) enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient’s information, thereby ensuring appropriate medication coverage based on the patient’s location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade’s fair online market platform targets the nation’s retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE’s programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.  
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks (“PAC”) to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry. 
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE’s advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process. 

Management Team 

Trxade’s management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade’s chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade’s full-time president and COO, and as a director since the company’s acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (MEDS), closed Friday's trading session at $5.53, off by 1.9504%, on 16,337 volume with 138 trades. The average volume for the last 3 months is 120,415 and the stock's 52-week low/high is $3.15000009/$11.6000003.

Recent News

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Friday's trading session at $2.60, up 5.2632%, on 19,616 volume with 82 trades. The average volume for the last 3 months is 16,156 and the stock's 52-week low/high is $0.600600004/$4.48999977.

Recent News

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Friday's trading session at $1.73, up 7.4534%, on 672,638 volume with 1,597 trades. The average volume for the last 3 months is 1,061,535 and the stock's 52-week low/high is $1.25/$8.50.

Recent News

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR)

The QualityStocks Daily Newsletter would like to spotlight Energy Fuels Inc. (UUUU).

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR), based in Lakewood, Colorado, is the country’s largest producer of uranium and the leading conventional producer of vanadium, both designated by the U.S. government as critical minerals.

As the leading U.S. diversified uranium miner, Energy Fuels’ uranium production portfolio stands apart in the world. Energy Fuels has more uranium production facilities, more production capacity, and more in-ground resources than any other company in the United States. In fact, the company’s assets have produced over one-third of all U.S. uranium over the past 15 years and is uniquely positioned to increase production to meet new demand.

Energy Fuels utilizes both conventional and in-situ recovery (“ISR”) technology to produce uranium from three strategic facilities:

  • White Mesa Mill in Utah (conventional) has a licensed capacity of over 8 million pounds of U3O8 per year. The highly strategic White Mesa Mill is the only conventional uranium mill in the country and is proximate to some of the largest and highest-grade uranium mines and projects in the U.S., including the Company’s Canyon mine, La Sal Complex, Henry Mountains Complex and Roca Honda Project. White Mesa Mill provides Energy Fuels with significant production scalability as uranium demand increases. The White Mesa Mill also has other diverse businesses, including vanadium, rare earth elements (REE’s), alternate feed materials recycling and land cleanup, all described below.
  • Nichols Ranch Plant (ISR) is located in the productive Powder River Basin district of Wyoming and has a total licensed capacity of 2 million pounds of U3O8 per year. Nichols Ranch has produced 1.2 million pounds of U3O8 since commissioning in 2014, and it has significant future expansion potential from 34 fully licensed wellfields containing significant in-ground uranium resources.
  • Alta Mesa Plant (ISR) is located on over 200,000 acres of private land in Texas. The fully licensed and constructed ISR project has a total operating capacity of 1.5 million pounds of uranium per year and produced nearly 5 million pounds of U3O8 between 2005 and 2013. This low-cost production facility is currently on standby, maintained in a state of readiness to respond to expected increases in demand.

In addition to being the largest uranium miner in the U.S., Energy Fuels’ overall portfolio also includes a pipeline of high-quality, large-scale exploration and development projects that are permitted or are in advanced stages of permitting, as well as an industry-leading U.S. NI 43-101 Mineral Resource portfolio.

FACTOID: Energy Fuels has led industry efforts over the past two-plus years to get the U.S. government to recognize the importance of domestically produced uranium, including the 2018 – 2019 Uranium Section 232, the ongoing Nuclear Fuel Working Group and the recently announced creation of the U.S. strategic uranium reserve. The U.S. is by far the largest consumer of uranium in the world, yet we import almost all of our requirements; Energy Fuels aims to change that.

Nuclear Market Potential

Multiple studies in top scientific journals have shown that nuclear power is cleanest and most economical way to produce reliable electricity as worldwide demand continues to soar. Nuclear power is presently the only available and affordable low-carbon power source that can meet both current and future baseload electricity demands while simultaneously reducing air pollution and mitigating climate change. U.S. nuclear power plants currently generate nearly 20% of the nation’s electricity overall and 55% of its carbon-free electricity and even a modest increase in electricity demand would require significant new nuclear capacity by 2025. According to the World Nuclear Association (WNA), there are currently 441 operable reactors, with another 54 units under construction and 439 in various stages of planning; in addition, the WNA has identified a potentially massive supply/demand gap through 2040 of 1 billion pounds. These factors among others are expected to significantly drive increased demand for uranium.

Reasons Nuclear is Gaining Traction

  • Nuclear reactors emit no greenhouse gases during operation. Over their full lifetimes, they result in comparable emissions to renewable forms of energy such as wind and solar.
  • Unlike any other form of energy, the waste from nuclear energy is contained and managed securely. Used fuel is currently being safely stored for ultimate disposal or future reprocessing, and 96% of this waste can potentially be recycled.
  • Greater demand for clean electricity to power everything from homes to automobiles, reducing dependence on fossil fuels.

No. 1 U.S. Producer of Vanadium in 2019

Energy Fuels also produces vanadium as a byproduct of uranium production. Vanadium is designated a critical mineral, essential to the economic and national security of the United States. Energy Fuels was the largest producer of vanadium in the U.S. in 2019, and has significant high-grade, in-ground vanadium resources, as well as a separate high-purity vanadium production circuit at their White Mesa Mill, which is also the only conventional vanadium mill in the country. Crucial for use in the steel, aerospace, and chemical industries, vanadium plays a critical role in the production of high-strength and light-weight metallic alloys and demand is expected to increase across the globe.

Energy Fuels has several fully permitted and developed standby mines containing large quantities of high-grade vanadium, along with uranium, including:

  • La Sal Complex (Utah)
  • Whirlwind Mine (Colorado/Utah)
  • Rim Mine (Colorado)

Vanadium has also gained increased attention as a catalyst in next-generation high-capacity, “community-scale” batteries used for energy storage generated from renewable sources. Demand is only expected to grow as this market expands. With recent upgrades in its vanadium production operations, in 2019 Energy Fuels produced commercial levels of the highest purity (99.7%) vanadium in the mill’s history and can rapidly adjust production to meet volatile market conditions. Energy Fuels is one of the very few known avenues that provides investors access the vanadium market.

Rare Earth Element (REE) Production, Alternate Feed Material Recycling, and Land Cleanup

The White Mesa Mill also provides the company with diverse cashflow generating opportunities. Security of supply for Rare Earth Elements (REEs) supporting U.S. military and defense requirements is a major issue today. Energy Fuels has been approached by a number of entities, including the U.S. government, inquiring about the potential to process certain REEs at the mill. The White Mesa Mill is currently licensed to process certain REEs, including tantalum and niobium. And, early indications are that the mill can be utilized to produce several other REEs. The White Mesa Mill is also the only facility in North America licensed and capable of recycling alternate feed materials (AFMs). AFMs are essentially low-level waste materials that contain recoverable quantities of natural (or unenriched) uranium. The Company typically generates between $5 and $15 million per year from AFM recycling. Finally, Energy Fuels is seeking to become involved in the cleanup of legacy Cold War era uranium mines in the Four Corners region of the U.S., including on the Navajo Nation. The U.S. Environmental Protection Agency (EPA) has access to over $1.5 billion for the cleanup of just a fraction of the sites on the Navajo Nation. The White Mesa Mill is fully licensed to receive much of this material, we are one of the government’s lowest cost options, and we have the ability to recycle the material and produce usable uranium from it.

Management Team

Mark S. Chalmers, President and CEO
Mark S. Chalmers is the president and chief executive officer of Energy Fuels, a position he has held since Feb. 1, 2018, following his role as chief operating officer of Energy Fuels from July 1, 2016 – Jan. 31, 2018. From 2011 to 2015, Chalmers served as executive general manager of Production for Paladin Energy Ltd., a uranium producer with assets in Australia and Africa, including the Langer Heinrich and Kayelekera mines where, as head of operations, he oversaw sustained, significant increases in production while reducing operating costs. He also possesses extensive experience in in situ recovery (“ISR”) uranium production, including management of the Beverley Uranium Mine owned by General Atomics (Australia), and the Highland mine owned by Cameco Corporation (USA). Chalmers has also consulted to several of the largest players in the uranium supply sector, including BHP Billiton, Rio Tinto, and Marubeni, and until recently served as the chair of the Australian Uranium Council, a position he held for 10 years. Chalmers is a registered professional engineer and holds a Bachelor of Science in Mining Engineering from the University of Arizona.

W. Paul Goranson, COO
W. Paul Goranson is the chief operating officer for Energy Fuels. Goranson has 30 years of mining, processing and regulatory experience in the uranium extraction industry that includes both conventional and in-situ recovery (“ISR”) mining, and he is a registered professional engineer. Prior to the acquisition by Energy Fuels of Uranerz Energy Corporation, Goranson served as president, chief operating officer and director for Uranerz, where he was responsible for operations of the Nichols Ranch ISR Uranium Project. In addition to those duties, he also managed uranium marketing, regulatory and government affairs, exploration and land. Prior to joining Uranerz, Goranson served as president of Cameco Resources, where he led the operations at the Smith Ranch-Highland, Crow Butte and North Butte ISR uranium recovery facilities. Goranson also served as vice president of Mesteña Uranium LLC, and he has served in senior positions with Rio Algom Mining, (a subsidiary of BHP Billiton), and Uranium Resource Inc. Goranson has a Bachelor of Science in Natural Gas Engineering from Texas A&I University, and a Master of Science in Environmental Engineering from Texas A&M University-Kingsville.

David C. Frydenlund, CFO, General Counsel, Corporate Secretary
David C. Frydenlund is chief financial officer, general counsel, and corporate secretary of Energy Fuels. His responsibilities include oversight of all legal matters relating to the company’s activities. His expertise extends to NRC, EPA, state and federal regulatory and environmental laws and regulations. From 1997 to 2012, Frydenlund was vice president of regulatory affairs, general counsel and corporate secretary of Denison Mines Corp., and its predecessor International Uranium Corporation (“IUC”). He also served as a director of IUC from 1997 to 2006 and CFO of IUC from 2000 to 2005. From 1996 to 1997, Frydenlund was vice president of the Lundin Group of international public mining and oil and gas companies, and prior thereto was a partner with the Vancouver law firm of Ladner Downs (now Borden Ladner Gervais) where his practice focused on corporate, securities and international mining transactions law. Frydenlund holds a bachelor’s degree in business and economics from Simon Fraser University, a master’s degree in economics and finance from the University of Chicago and a law degree from the University of Toronto.

Curtis H. Moore, Vice President of Marketing and Corporate Development
Curtis H. Moore is the vice president of Marketing and Corporate Development for Energy Fuels. He oversees product marketing for Energy Fuels, and is closely involved in mergers & acquisitions, investor relations, public relations, and corporate legal. He has been with Energy Fuels for over 12 years, holding various roles of increasing responsibility. Prior to joining Energy Fuels, Moore worked in multi-family real estate development, government relations and public affairs, production homebuilding, and private law practice. Moore is a licensed attorney in the State of Colorado. He holds Juris Doctor and MBA degrees from the University of Colorado at Boulder, and a Bachelor of Arts dual degree in Economics-Government from Claremont McKenna College in Claremont, California.

 

Energy Fuels Inc. (UUUU), closed Friday's trading session at $1.65, off by 1.7857%, on 1,153,336 volume with 3,361 trades. The average volume for the last 3 months is 1,614,139 and the stock's 52-week low/high is $0.779999971/$3.31999993.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.